K2 Therapeutics raises US$50M to build global biotech pipeline from Singapore

Singapore’s biotech sector has long had the ingredients of a serious life sciences hub: strong universities, public research funding, hospital networks, and a government keen to pull high-value industries into the city-state. What it has had less of is a steady stream of venture-backed drug…